blood bag News
-
Puriblood relying on unique technolog to grab the Global 27.7 billion Blood Market
Complementary with Formosa Plastics technology to build Taiwan’s first blood bag system factory Xue Guangying revealed that as early as more than a decade ago, Formosa Plastics had commissioned the Plastics Center to assess whether it had a chance to enter the international blood consumables market or not. Later, the plan was temporarily put on hold, not because of the lack of funds of ...
-
BloodCenter of Wisconsin and Eastman Chemical Company announce new blood bag clinical trial results
BloodCenter of Wisconsin (BCW, part of Versiti) and Eastman Chemical Company (NYSE:EMN) have announced the results of a recent clinical trial evaluating a new plasticizer for blood bags. While di-2-ethylhexyl phthalate (DEHP) has provided the medical industry with a stable ortho-phthalate plasticizer for many years, regulatory trends and consumer demands will inevitably drive the industry to ...
-
Improve Staff Productivity
ZipThaw is a blood product thawer that uses revolutionary dry technology to quickly thaw blood products for patients in need. ZipThaw is dry, so there’s no messes like with water baths, and fast, so you can increase your thawed plasma throughput — it’s also easy for staffers to use. With simple thawing, staffers can spend their time elsewhere on other critical tasks. Last ...
-
Anxin medicine introduces you to the secrets of medical polymer materials
Medical polymer materials for the first time into the line of sight of people in 1949, is the first published the prospect of medical polymer materials, for the first time introduced the use of poly (methyl methacrylate as a person's skull, joint and femoral, using polyamide as the clinical application of surgical suture, since then, usher in rapid development of medical polymer materials, is ...
-
Grifols reaches revenue of EUR 5,100 million, a 13.6% increase, and raises its profits to EUR 625 million
Revenue increases 13.6% (9.2% cc) as a result of the sustainable growth strategy, with advances in all divisions and regions Bioscience leads the growth with EUR 3,994 million of revenue (13.6%; 8.9% cc). Diagnostic and Hospital continue to make progress with sales of EUR 734 million (4.5%; 1.1% cc) and EUR 134 million (12.5%; 12.1% cc), respectively. Bio Supplies achieves EUR 267 million in ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you